Back
Y-mAbs Therapeutics Vs. The Cooper Companies Industry Stock Comparison
Sell
39
YMAB
Y-mAbs Therapeutics
Last Price:
12.85
Seasonality Move:
18.11%
Buy
66
COO
The Cooper Companies
Last Price:
94.72
Seasonality Move:
2.09%
Sell
39
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy, Sell or Hold?
- The current Y-mAbs Therapeutics [YMAB] share price is $13.61. The Score for YMAB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
The Cooper Companies (COO)
is a Buy
Is The Cooper Companies a Buy, Sell or Hold?
- The current The Cooper Companies [COO] share price is $91.99. The Score for COO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- COO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
YMAB Stock Price Chart
What is Y-mAbs Therapeutics's stock price today?
-
The Y-mAbs Therapeutics share price today is $13.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing slight selling pressure.
COO Stock Price Chart
What is The Cooper Companies's stock price today?
-
The The Cooper Companies share price today is $91.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COO is experiencing selling pressure, which indicates risk of future bearish movement.
YMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 37.55 | Sell |
| Chaikin Money Flow: | -737281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.19 - 16.27) | Sell |
| Bollinger Bands (100): | (9.56 - 16.9) | Buy |
COO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 46.69 | Sell |
| Chaikin Money Flow: | -524532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.14 - 95.84) | Sell |
| Bollinger Bands (100): | (91.36 - 99.24) | Sell |
YMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.21 | Sell |
| 20-day SMA: | 15.47 | Sell |
| 50-day SMA: | 15.69 | Sell |
| 200-day SMA: | 9.39 | Buy |
| 8-day EMA: | 15.91 | Sell |
| 20-day EMA: | 15.66 | Sell |
| 50-day EMA: | 15.06 | Sell |
| 200-day EMA: | 11.19 | Buy |
COO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.85 | Buy |
| 20-day SMA: | 91.02 | Buy |
| 50-day SMA: | 96.55 | Sell |
| 200-day SMA: | 90.76 | Buy |
| 8-day EMA: | 91.41 | Buy |
| 20-day EMA: | 92.1 | Sell |
| 50-day EMA: | 94.08 | Sell |
| 200-day EMA: | 92.09 | Sell |
Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.27 per share.
The Cooper Companies Earnings Growth & COO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.34 per share, and an increase next year of $0.40 per share.
Y-mAbs Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
The Cooper Companies Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||